Application of Long Noncoding RNAs in Osteosarcoma: Biomarkers and Therapeutic Targets
Osteosarcoma is the most common primary bone malignancy in children and adolescents. Although improvements in therapeutic strategies were achieved, the outcome remains poor for most patients with metastatic or recurrent osteosarcoma. Therefore, it is imperative to identify novel and effective progno...
Main Authors: | Zhihong Li, Pengcheng Dou, Tang Liu, Shasha He |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2017-07-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/479205 |
Similar Items
-
A five metastasis-related long noncoding RNA risk signature for osteosarcoma survival prediction
by: SiYuan Yu, et al.
Published: (2021-05-01) -
Potential Roles of Long Noncoding RNAs as Therapeutic Targets in Renal Fibrosis
by: Hyun Jin Jung, et al.
Published: (2020-04-01) -
The role of long noncoding RNAs in hepatocellular carcinoma
by: Zhao Huang, et al.
Published: (2020-04-01) -
The Roles of Noncoding RNAs in the Development of Osteosarcoma Stem Cells and Potential Therapeutic Targets
by: Jinxin Liu, et al.
Published: (2022-02-01) -
Glycation-Associated Diabetic Nephropathy and the Role of Long Noncoding RNAs
by: Ankita Durge, et al.
Published: (2022-10-01)